October 4, 2006

Contact: Lauren Cruse (505) 272-3690

FOR IMMEDIATE RELEASE

Alexandria, Va.-The University of New Mexico College of Pharmacy (UNM COP) was one of 11 colleges in the nation highlighted in the recently issued American Association of Colleges of Pharmacy (AACP) report, Pilot Project to Profile Exemplary Advanced Practice Experience Sites.

The report was part of the Academic-Practice Partnership Initiative (APPI) program that the AACP started in 2004 to enhance the quality of pharmacy education in exemplary patient care environments by expanding experiential learning opportunities for students through partnership with practicing pharmacist preceptors.

The UNM COP was highlighted with 10 other pharmacy institutions that included: University of Southern California, Los Angeles, Calif.; Nova Southeastern University, Fort Lauderdale, Fla.; University of Illinois at Chicago, Chicago, Ill.; Drake University, Des Moines, Iowa; University of Maryland, Baltimore Md.; Northeastern University, Boston, Mass.; The University of Mississippi, University, Miss.; University of Cincinnati, Cincinnati, Ohio; University of Texas, Austin, Texas; and University of Washington, Seattle, Wash.

These colleges and schools of pharmacy were identified by the AACP as high-quality experiential teaching sites for fourth-year pharmacy students.

"This initiative is a huge step in advancing the quality and depth of experiential education for tomorrow's pharmacists," said Lucinda L. Maine, PhD, executive vice president of AACP. "The success of these pilot schools really illustrates how a learning partnership can be a win-win for all involved. We are grateful to each of the 11 schools for helping AACP move forward with this worthy initiative. All of them will serve as examples for the continued development of applied learning programs in pharmacy education."

The AACP is a national organization whose mission is to serve its member colleges, schools and their faculty by acting as their advocate on a national level. The association is committed to education and scholarship for improving drug therapy.